<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The recurrent translocation t(11;16)(q23;p13) has been reported to be associated with therapy-related <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The MLL gene involved in other 11q23 abnormalities was also rearranged by this translocation </plain></SENT>
<SENT sid="2" pm="."><plain>We analyzed two patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> with t(11;16) and showed that the MLL gene on 11q23 was fused with CREB-binding protein (CBP) gene on 16p13 in these patients </plain></SENT>
<SENT sid="3" pm="."><plain>The CBP gene encodes a transcriptional adaptor/coactivator protein and it is mutated in patients with Rubinstein-<z:e sem="disease" ids="C0265251" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Taybi syndrome</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The CBP gene is also involved in <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) with t(8;16)(p11;p13) </plain></SENT>
<SENT sid="5" pm="."><plain>In-frame MLL-CBP fusion transcripts combine the MLL AT-hook motifs and DNA methyltransferase homology region with a largely intact CBP </plain></SENT>
<SENT sid="6" pm="."><plain>Our results combined with the finding of the MOZ-CBP fusion in t(8;16)-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> suggest that the CBP gene may be associated with <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">leukemogenesis</z:e> through translocations </plain></SENT>
</text></document>